Detalle de: The Production of Recombinant African Swine Fever Virus Lv17/WB/Rie1 Strains and Their In Vitro and In Vivo Characterizations
| Title | The Production of Recombinant African Swine Fever Virus Lv17/WB/Rie1 Strains and Their In Vitro and In Vivo Characterizations |
| Abstract |
Lv17/WB/Rie1-Δ24 was produced via illegitimate recombination mediated by low-dilution serial passage in the Cos7 cell line and isolated on PAM cell culture. The virus contains a huge ~26.4 Kb deletion in the left end of its genome. Lv17/WB/Rie1-ΔCD-ΔGL was generated via homologous recombination, crossing two ASFV strains (Lv17/WB/Rie1-ΔCD and Lv17/WB/Rie1-ΔGL containing eGFP and mCherry markers) during PAM co-infection. The presence of unique parental markers in the Lv17/WB/Rie1-ΔCD-ΔGL genome indicates at least two recombination events during the crossing, suggesting that homologous recombination is a relatively frequent event in the ASFV genome during replication in PAM. Pigs infected with Lv17/WB/Rie1-Δ24 and Lv17/WB/Rie1/ΔCD-ΔGL strains have shown mild clinical signs despite that ASFV could not be detected in their sera until a challenge infection with the Armenia/07 ASFV strain. The two viruses were not able to induce protective immunity in pigs against a virulent Armenia/07 challenge. |
| Apa Reference | Petrini, S., Righi, C., Mészáros, I., D’Errico, F., Tamás, V., Pela, M., Olasz, F., Gallardo, C., Fernandez-Pinero, J., Göltl, E., Magyar, T., Feliziani, F. & Zádori, Z. (2023). The Production of Recombinant African Swine Fever Virus Lv17/WB/Rie1 Strains and Their In Vitro and In Vivo Characterizations. Vaccines, 11(12), 1860. 10.3390/vaccines11121860 |
| Doi | 10.3390/vaccines11121860 |
| Publication Date | 17 Dec 2023 |
| Publication Type | Article |
| Researcher | Jovita Fernández Pinero |
| Ontology | Animal health |
| Research Groups | |
| Tools |
